or Try an Advanced Search...

    Technical Analysis for CRSP - CRISPR Therapeutics AG

    Grade Last Price % Change Price Change
    C 47.93 -2.06% -1.01
    CRSP closed down 2.06 percent on Wednesday, October 30, 2024, on 1.15 times normal volume.
    Earnings due: Nov 4
    *** please verify all earnings dates ***
    8 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Flat
    Historical CRSP trend table...
    Date Alert Name Type % Chg
    Outside Day Range Expansion 0.00%
    Gapped Down Weakness 0.00%
    Inside Day Range Contraction -2.06%
    Multiple of Ten Bearish Other -3.58%
    Gapped Up Strength -3.58%
    Upper Bollinger Band Touch Strength -3.58%
    Crossed Above 20 DMA Bullish -0.04%
    Crossed Above 50 DMA Bullish -0.04%
    180 Bullish Setup Bullish Swing Setup -0.04%
    Fell Below 20 DMA Bearish 4.20%
    Older End-of-Day Signals for CRSP ...

       Recent Intraday Alerts

    Alert Time
    Down 2 % about 14 hours ago
    Fell Below 10 DMA about 15 hours ago
    60 Minute Opening Range Breakdown about 15 hours ago
    Rose Above Previous Day's High about 17 hours ago
    Outside Day about 17 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    CRSP Chart by TradingView
    Basic chart:

    Profile

    Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct disease-associated deoxyribonucleic acid (DNA) in a patient’s cell. The location at which the Cas9 molecular scissors cut the DNA to be edited is specified by guide ribonucleic acid (RNA), which is comprised of a crRNA component and a tracrRNA component, either individually or combined together as a single guide RNA. The Company has business operations in London, the United Kingdom, as well as research and development operations in Cambridge, the United States.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biology Immune System Acid Genetics Enzymes Genetic Engineering Precision Medicine CRISPR DNA Genome Editing Cas9

    Is CRSP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 30 Crispr Therapeutics: Avoid Catching The Falling Knife This Time (Downgrade)
    Oct 28 CRISPR Therapeutics to Report Q3 Earnings: Is a Beat in Store?
    Oct 28 Crispr Therapeutics: Poised For A Major Turnaround
    Oct 26 The Ultimate Biotech Stock to Buy With $50 Right Now
    Oct 25 Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma
    Oct 24 5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright
    Oct 21 CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know
    Oct 21 Wall Street Analysts See a 67.54% Upside in CRISPR Therapeutics (CRSP): Can the Stock Really Move This High?
    Oct 19 We Think CRISPR Therapeutics (NASDAQ:CRSP) Can Easily Afford To Drive Business Growth
    Oct 19 3 Bargain Stocks to Buy in a Market That's Priced for Perfection
    See more CRSP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 91.1
    52 Week Low 43.42
    Average Volume 1,009,452
    200-Day Moving Average 58.31
    50-Day Moving Average 47.18
    20-Day Moving Average 47.26
    10-Day Moving Average 48.17
    Average True Range 1.67
    RSI (14) 51.22
    ADX 15.93
    +DI 20.05
    -DI 18.89
    Chandelier Exit (Long, 3 ATRs) 45.49
    Chandelier Exit (Short, 3 ATRs) 49.45
    Upper Bollinger Bands 50.25
    Lower Bollinger Band 44.26
    Percent B (%b) 0.61
    BandWidth 12.69
    MACD Line 0.35
    MACD Signal Line 0.19
    MACD Histogram 0.1574
    Fundamentals Value
    Market Cap 3.81 Billion
    Num Shares 79.4 Million
    EPS -4.47
    Price-to-Earnings (P/E) Ratio -10.72
    Price-to-Sales 34.65
    Price-to-Book 3.22
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 51.34
    Resistance 3 (R3) 51.61 50.74 50.77
    Resistance 2 (R2) 50.74 49.87 50.60 50.58
    Resistance 1 (R1) 49.33 49.33 48.90 49.07 50.39
    Pivot Point 48.47 48.47 48.25 48.33 48.47
    Support 1 (S1) 47.06 47.60 46.63 46.79 45.47
    Support 2 (S2) 46.20 47.06 46.06 45.28
    Support 3 (S3) 44.79 46.20 45.09
    Support 4 (S4) 44.52